News

With this move, Covance will build strategic relationships with investigators, sites, and regulatory authorities in a region known for its potential to contribute to high-quality global clinical trial

Ms Hagerty succeeds Lawrence Dolin, co-founder of Noteworthy. Mr Dolin will continue to serve on the board of directors and work with the company as a consultant. Ms

Mr Broek is founder and managing partner of HSMR Advisors, a US-based fund manager with an investment emphasis on small and mid-cap biotech public companies. During his career

Before Humana, Lord was president of Health Dialog in Boston, where he helped pioneer e-enabled health care. He has also served as chief operating officer of the American

SARcode, a biopharmaceutical company, has announced the results of its Phase I randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of

Halozyme Therapeutics, a biopharmaceutical company, has commenced patient dosing in a Phase I clinical trial with PEGPH20 in cancer patients with refractory solid tumors. This multi-center, open-label, dose-escalation

Dr Seide has over 23 years of experience as a patent attorney, with the majority of it focused in the life sciences industry. Her experience encompasses all facets

The medication is a generic version of Wyeth’s Tazocin, an injectable antibiotic. Hospira will offer piperacillin/tazobactam as a powder for solution for injection or infusion in 2.25g and

The Phase II, double-blind, vehicle-controlled study will determine the efficacy, safety and tolerability of SRD441 in patients with atopic dermatitis (AD). Results from the Phase II study for